Scientific paper - Original scientific paper
A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial
Therapeutics and Clinical Risk Management, 14 (2018); 741-745. https://doi.org/10.2147/TCRM.S160778

Belavić, Matija; Sotošek Tokmadžić, Vlatka; Brozović Krijan, Antonija; Kvaternik, Ines; Matijaš, Kristina; Strikić, Nedjeljko; Žunić, Josip

Cite this document

Belavić, M., Sotošek Tokmadžić, V., Brozović Krijan, A., Kvaternik, I., Matijaš, K., Strikić, N. & Žunić, J. (2018). A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial. Therapeutics and Clinical Risk Management, 14., 741-745. doi: 10.2147/TCRM.S160778

Belavić, Matija, et al. "A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial." Therapeutics and Clinical Risk Management, vol. 14, 2018, pp. 741-745. https://doi.org/10.2147/TCRM.S160778

Belavić, Matija, Vlatka Sotošek Tokmadžić, Antonija Brozović Krijan, Ines Kvaternik, Kristina Matijaš, Nedjeljko Strikić and Josip Žunić. "A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial." Therapeutics and Clinical Risk Management 14 (2018): 741-745. https://doi.org/10.2147/TCRM.S160778

Belavić, M., et al. (2018) 'A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial', Therapeutics and Clinical Risk Management, 14, pp. 741-745. doi: 10.2147/TCRM.S160778

Belavić M, Sotošek Tokmadžić V, Brozović Krijan A, Kvaternik I, Matijaš K, Strikić N, and sur.. A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial. Therapeutics and Clinical Risk Management [Internet]. 2018 April [cited 2024 December 07];14:741-745. doi: 10.2147/TCRM.S160778

M. Belavić, et al., "A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial", Therapeutics and Clinical Risk Management, vol. 14, pp. 741-745, April 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:441313. [Accessed: 07 December 2024]

Please login to the repository to save this object to your list.